Manulife (Manufacturers Life Insurance)
NVRO

Manulife (Manufacturers Life Insurance)’s NEVRO CORP. NVRO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,865
Closed -$86.8K – 3031
2025
Q1 		$86.8K Sell
14,865
-2
-0% -$11 ﹤0.01% 2732
2024
Q4 		$55.3K Buy
14,867
+489
+3% +$2.26K ﹤0.01% 2929
2024
Q3 		$80.4K Sell
14,378
-424
-3% -$2.97K ﹤0.01% 2915
2024
Q2 		$125K Buy
14,802
+1,600
+12% +$17.1K ﹤0.01% 2764
2024
Q1 		$191K Sell
13,202
-677
-5% -$11.2K ﹤0.01% 2612
2023
Q4 		$299K Hold
13,879
– – ﹤0.01% 2415
2023
Q3 		$267K Sell
13,879
-22,506
-62% -$480K ﹤0.01% 2432
2023
Q2 		$925K Buy
36,385
+2,075
+6% +$59.9K ﹤0.01% 1696
2023
Q1 		$1.24M Buy
34,310
+14
+0% +$492 ﹤0.01% 1531
2022
Q4 		$1.37M Buy
34,296
+5,054
+17% +$210K ﹤0.01% 1491
2022
Q3 		$1.37M Sell
29,242
-191
-0.6% -$8.86K ﹤0.01% 1486
2022
Q2 		$1.32M Sell
29,433
-247
-0.8% -$13.6K ﹤0.01% 1530
2022
Q1 		$2.14M Buy
29,680
+12,086
+69% +$871K ﹤0.01% 1481
2021
Q4 		$1.43K Sell
17,594
-113
-0.6% -$11.3K ﹤0.01% 1632
2021
Q3 		$2.06M Sell
17,707
-1,567
-8% -$205K ﹤0.01% 1490
2021
Q2 		$3.19M Buy
19,274
+269
+1% +$42K ﹤0.01% 1444
2021
Q1 		$2.65M Sell
19,005
-1,151
-6% -$188K ﹤0.01% 1461
2020
Q4 		$3.49M Buy
20,156
+920
+5% +$149K ﹤0.01% 1361
2020
Q3 		$2.68M Sell
19,236
-608
-3% -$81.2K ﹤0.01% 1341
2020
Q2 		$2.34M Buy
19,844
+972
+5% +$115K ﹤0.01% 1365
2020
Q1 		$1.89M Sell
18,872
-64,615
-77% -$7.77M ﹤0.01% 1316
2019
Q4 		$9.81M Sell
83,487
-3,077
-4% -$305K 0.01% 849
2019
Q3 		$7.31M Sell
86,564
-76,052
-47% -$5.75M 0.01% 998
2019
Q2 		$10.5M Sell
162,616
-667
-0.4% -$41.5K 0.01% 811
2019
Q1 		$10.2M Sell
163,283
-123,050
-43% -$5.79M 0.01% 844
2018
Q4 		$11.1M Buy
286,333
+267,556
+1,425% +$11.9M 0.01% 723
2018
Q3 		$1.07M Sell
18,777
-2,561
-12% -$160K ﹤0.01% 1753
2018
Q2 		$1.7M Buy
21,338
+479
+2% +$39.7K ﹤0.01% 1561
2018
Q1 		$1.81M Sell
20,859
-298
-1% -$24.1K ﹤0.01% 1523
2017
Q4 		$1.46M Buy
21,157
+88
+0.4% +$7.04K ﹤0.01% 1636
2017
Q3 		$1.92M Sell
21,069
-340
-2% -$29.1K ﹤0.01% 1451
2017
Q2 		$1.59M Buy
21,409
+2,795
+15% +$224K ﹤0.01% 1546
2017
Q1 		$1.75M Buy
18,614
+2,229
+14% +$202K ﹤0.01% 1465
2016
Q4 		$1.19M Buy
16,385
+6
+0% +$514 ﹤0.01% 1596
2016
Q3 		$1.71M Buy
16,379
+123
+0.8% +$11.1K ﹤0.01% 1420
2016
Q2 		$1.2M Buy
16,256
+4,848
+42% +$329K ﹤0.01% 1519
2016
Q1 		$631K Buy
11,408
+399
+4% +$23.5K ﹤0.01% 1847
2015
Q4 		$743 Buy
11,009
+106
+1% +$5.68K ﹤0.01% 1778
2015
Q3 		$506 Buy
10,903
+1,019
+10% +$49.4K ﹤0.01% 1997
2015
Q2 		$531 Buy
9,884
+4,751
+93% +$242K ﹤0.01% 2079
2015
Q1 		$246 Buy
5,133
+3,107
+153% +$135K ﹤0.01% 2580
2014
Q4 		$78 Buy
+2,026
New +$63.8K ﹤0.01% 3137

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NVRO Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 14,865 shares — an estimated $86.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $11.1M in Q4 2018. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,865 NEVRO CORP. shares in Q2 2025, an estimated $86.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
  • Manulife (Manufacturers Life Insurance)'s NEVRO CORP. position peaked at $11.1M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.